Logo
x

Search

Subscribe Now

Autoimmune disease

Selecta Enters into an Exclusive License Agreement with Genovis to Advance IgG Protease in Gene Therapy and Autoimmune Disease

Selecta Enters into an Exclusive License Agreement with Genovis to Advance IgG Protease in Gene Therapy and Autoimmune Disease

  • October 22, 2021
FibroGen Collaborates with HiFiBiO to Advance Next-Generation Therapies for Patients with Cancer and Autoimmune Disease

FibroGen Collaborates with HiFiBiO to Advance Next-Generation Therapies for Patients with Cancer and Autoimmune Disease

  • June 21, 2021
Takeda and KSQ Collaborate to Develop and Commercialize Novel Immuno-Oncology Therapies

Takeda and KSQ Collaborate to Develop and Commercialize Novel Immuno-Oncology Therapies

  • January 15, 2021
Henlius Receives the NMPA's Approval for HLX03 (biosimilar- adalimumab) to Treat Autoimmune Disease

Henlius Receives the NMPA's Approval for HLX03 (biosimilar- adalimumab) to Treat Autoimmune Disease

  • December 7, 2020
Henlius Present Results of HLX03 (biosimilar- adalimumab) in P-lll Study for Plaque Psoriasis at EADV 2020

Henlius Present Results of HLX03 (biosimilar- adalimumab) in P-lll Study for Plaque Psoriasis at EADV 2020

  • October 29, 2020
Innovent and Lilly's Halpryza (biosimilar- rituximab) Receive NMPA's Approval in China

Innovent and Lilly's Halpryza (biosimilar- rituximab) Receive NMPA's Approval in China

  • October 12, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.